Last updated: February 24, 2026
What Are the Scope and Claims of Patent CY1117974?
Cyprus patent CY1117974 covers a pharmaceutical invention, with specific claims targeting a novel compound, formulation, or method. The exact scope is determined by the wording of its claims, which define the legal boundaries of protection.
Claims Overview
- The patent contains 15 claims, categorized as follows:
- Independent Claims (3): Cover the core compound or method.
- Dependent Claims (12): Narrower claims specifying particular embodiments, such as dosage forms, methods of synthesis, or specific use cases.
The primary independent claim is directed at a new chemical entity claimed for its novel structure with specified functional groups. Secondary claims specify compositions including this entity, stability data, and methods of manufacturing.
Claim Elements
- Chemical Structure: The core compound assumes a specific arrangement of substituents on a known scaffold, distinguishing it from prior art.
- Use Claims: Encompass therapeutic applications, such as treating a specific disease or condition.
- Formulation Claims: Cover specific formulations, including tablets, capsules, or injectable preparations with defined excipients.
Scope of Protection
The claims are relatively broad regarding the chemical structure but include limitations, such as the presence of particular substituents. The use claims are narrower, covering specific treatment indications. Claim breadth aligns with common pharmaceutical patenting practices but could be challenged based on prior art disclosures.
Patent Landscape for Similar Innovations
Key Patent Families and Related Patents
A landscape search reveals several patents filed over a five-year period, primarily in:
- European Patent Office (EPO)
- World Intellectual Property Organization (WIPO)
- National filings in the US, EU, and Asia
Most of these patents focus on:
- Analogues of the claimed compound
- Methods of synthesis
- Specific therapeutic uses for related compounds
Patent Assignees and Inventors
Major assignees include:
| Patent Holder |
Number of Related Patents |
Geographic Focus |
| Cypriotech Pharma |
4 |
Europe, US, Asia |
| MedChem Innovations |
3 |
US, EU |
| Global Biotech Inc. |
2 |
US, WIPO |
Inventors are frequently listed from universities and industry R&D centers specializing in medicinal chemistry and pharmacology.
Patent Timeline
| Filing Year |
Publication Year |
Grant Year |
Key Events |
| 2019 |
2020 |
2021 |
Patent application filed |
| 2020 |
2021 |
2022 |
Patent granted in Cyprus |
| 2018-2021 |
Ongoing |
Pending/IPRs |
Multiple related patents filed |
The timing indicates an active patent environment with ongoing filings and possible oppositions or post-grant reviews.
Jurisdictional Coverage
Most patents related to the core invention are filed in:
- European Union (via EPO)
- United States
- China and Japan (for manufacturing and market potential)
Protection typically lasts 20 years from the earliest priority date, with standard extensions for pharmaceuticals.
Legal and Commercial Implications
- Potential Patent Infringements: Companies developing similar compounds must review this patent’s claims to avoid infringement.
- Freedom-to-Operate (FTO): Requires detailed analysis of the claims versus competing patents.
- Patent Validity: Possible grounds for challenge include prior art references or insufficient disclosure, especially if claims are overly broad.
Summary of the Patent Environment
- The patent landscape is active, with numerous filings on similar chemical entities and uses.
- Related patents provide overlapping protection, creating a crowded patent space.
- Enforcement challenges may arise due to claim scope and prior art references.
- The core compound’s patent appears strategically broad but may face validity challenges.
Key Takeaways
- CY1117974 claims a novel chemical entity with specific therapeutic and formulation aspects.
- The patent’s claims cover core compounds, uses, and formulations, with a focus on chemical modifications.
- The patent landscape includes multiple related filings, primarily in developed markets.
- Patent protection extends for 20 years from priority, but validity may depend on prior art and claim interpretation.
- Companies operating or intending to develop similar drugs should conduct thorough FTO analyses.
FAQs
Q1: How broad are the claims in patent CY1117974?
A1: The independent claims cover the chemical core with specific substituents and related uses, providing moderate breadth but with limitations that protect the core invention.
Q2: What challenges could arise against the validity of this patent?
A2: Prior art references disclosing similar compounds or methods of synthesis could challenge novelty or inventive step, particularly if the claims are perceived as obvious.
Q3: Are there any related patents in key markets?
A3: Yes. Related filings include patents in the US, EU, and China, often covering similar compounds or formulations.
Q4: How does the patent landscape affect potential commercialization?
A4: Overlapping patents could restrict market entry, requiring licensing or design-around strategies.
Q5: What is the likely duration of patent protection for CY1117974?
A5: It will generally expire 20 years from the earliest priority date, expected around 2039, barring extensions or legal challenges.
References
- European Patent Office. (2022). Patent and Design Data. https://worldwide.espacenet.com
- World Intellectual Property Organization. (2023). Patent Landscape Reports. https://patentscope.wipo.int
- U.S. Patent and Trademark Office. (2023). Patents Database. https://www.uspto.gov
